April 2, 2019
C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage
C3J’s pending merger with AmpliPhi Biosciences, which will create a clinical-stage phage leader, is on track to close in May…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: C3J Therapeutics